Stay updated on DAPA-MI Trial: Dapagliflozin Post Heart Attack
Sign up to get notified when there's something new on the DAPA-MI Trial: Dapagliflozin Post Heart Attack page.

Latest updates to the DAPA-MI Trial: Dapagliflozin Post Heart Attack page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision entry v3.5.2 was added and v3.5.0 was removed from the record history.SummaryDifference0.1%

- Check17 days agoChange DetectedThe history shows frequent revisions to study status, contacts/locations, and key study sections across multiple versions. This reflects ongoing maintenance of the trial record and updates to how and where the trial is described.SummaryDifference0.1%

- Check32 days agoChange Detected- Revision v3.5.0 was added and revision v3.4.3 was removed from the history. This is a metadata/version update and does not alter the study data or eligibility information.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page history shows Revision: v3.4.3 added and Revision: v3.4.2 removed. This appears to be a minor site version update rather than changes to the study data or records.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded Revision: v3.4.2 and removed the notices about government funding lapse and related operating-status details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check81 days agoChange DetectedAdded a site-wide notice about potential delays due to a lapse in government funding and updated the page revision to v3.4.1. The previous revision reference v3.4.0 was removed.SummaryDifference0.5%

Stay in the know with updates to DAPA-MI Trial: Dapagliflozin Post Heart Attack
Enter your email address, and we'll notify you when there's something new on the DAPA-MI Trial: Dapagliflozin Post Heart Attack page.